Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

UFS honours Dr Ben Ngubane
2010-05-19

 
 Prof. Teuns Verschoor, acting Rector and Vice-Chancellor of the UFS, and Dr Ben Ngubane.
Photo: Stephen Collett


The University of the Free State (UFS) yesterday conferred an honorary doctorate on Dr Ben Ngubane, Chairperson of the SABC Board, during its autumn graduation ceremony held on the South Campus in Bloemfontein.

Dr Ngubane received the degree Philosophiae Doctor (Honoris Causa) for his immense contribution towards positioning South Africa as a major and an influential player in the development of arts, culture, science and technology internationally.

“I want to thank the UFS for this honour bestowed on me and accept this honorary doctorate in all humility and with great gratitude. I am comfortable to regard myself inextricably part of this university and its mission and will always be a worthy ambassador for this institution and what it represents. I am a proud Kovsie!” said Dr Ngubane after receiving the honorary doctorate.

“The world is changing at a rapid pace. Universities not only respond to such changes, they have become critical engines in the reshaping of that world through knowledge production and research innovation. Sitting at the tip of the African continent, and in the centre of South Africa, it is crucial to the ambitions and agendas of the UFS to be constantly aware of how the world of knowledge, innovation and scholarship is changing with respect to higher education, and how the UFS can best contribute to and benefit from such changes,” he said.

“A university worthy of its name thrives on the universality of ideas and people that come with the cross-currents of international scholars and students on its campus. The International Institute for Studies in Race, Reconciliation and Social Justice, to be launched shortly at the UFS has the potential to become a leading centre of scholarship acknowledged globally.”

Dr Ngubane said that the UFS is now well positioned and has the right strategies in place to become truly internationally recognised, with a proven ability to deal successfully with diversity, embedding in its students a humaneness and respect for the dignity of others, as well as an institution with an increasing through-put rate and with research outputs displaying excellence at international level.

Dr Ngubane was the first Minister of Arts, Culture, Science and Technology in the new, democratic South Africa appointed by the former President, Nelson Mandela, in 1994. He was re-appointed to lead this ministry again by former President Thabo Mbeki in 1999.

As Premier of KwaZulu-Natal from 1996 to 1999, Dr Ngubane is credited for his role in bringing about peace and reducing the political violence that ravaged the province at that time. In 2004 he was appointed as Ambassador to Japan where he initiated, among other projects, the South Africa-Japan University Forum (SAJU).

He holds Honorary Doctorates from the universities of Natal, Zululand, the Medical University of South Africa (Medunsa) and the Tshwane University of Technology.

Media Release
Issued by: Lacea Loader
Director: Strategic Communication (acting)
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl@ufs.ac.za  
19 May 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept